NSC |
Compound |
Enrichment |
Correlation |
NSC 663337 |
Null |
0.00234598979824212 |
-0.033136754 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0026598958355165 |
0.27857235 |
NSC 724783 |
[1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 |
0.0026598958355165 |
0.13191477 |
NSC 725098 |
Null |
0.0026598958355165 |
-0.061061546 |
NSC 755442 |
Null |
0.0026598958355165 |
0.20237344 |
NSC 81280 |
Null |
0.0026598958355165 |
0.1934896 |
NSC 3091 |
Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) |
0.00272369215216526 |
0.068184107 |
NSC 381866 |
BAFILOMYCIN DERIV. |
0.0027236921521653 |
0.00082400314 |
NSC 404027 |
Null |
0.0027236921521653 |
-0.1880016 |
NSC 633781 |
1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate |
0.0027236921521653 |
0.26606398 |